
AYA Biosciences: Data-driven biotech firm creating unique therapeutics for diverse disorders.
AYA Biosciences, founded with a mission to revolutionize the treatment of addiction, anxiety, sleep disorders, and diet disorders, is a data-driven biotechnology and biodiscovery company. The firm specializes in creating differentiated psychedelic and plant-based therapeutics, aiming to provide accessible biopharmaceutical formulations for diverse diseases. Their market focus is on leveraging botanical medicine, backed by clinical studies, to offer innovative solutions for mental health and wellness.
Notable affiliated people and investors include experts in biotechnology and pharmacology, although specific names are not provided. Key achievements involve pioneering research in rare cannabinoids and advancing botanical extraction methods through their partnership with LEEF Labs. AYA Biosciences' impact lies in its commitment to clinical efficacy and ongoing research, setting new standards in the biotech industry for treating complex disorders with plant-based therapeutics.

Aytu BioPharma
aytubio.com

Freedom Biosciences
freedombio.co

Aureka Biotechnologies
aurekabio.com

Aether Therapeutics

Aibios
aibios.com

Reset Pharmaceuticals

Lykos Therapeutics
lykospbc.com

Alaya.bio
alaya.bio

Applied Biosciences

Enveda Biosciences
envedabio.com

AyuVis Research
ayuvis.com

Actio Biosciences
actiobio.com

Gilgamesh Pharmaceuticals

Woven Science
woven.science

Regenerative Bio
regen-bio.us
Companies similar to Aya Biosciences include Aytu BioPharma, Freedom Biosciences, Aureka Biotechnologies and Aether Therapeutics.
Aya Biosciences was founded in 2020.
Aya Biosciences' headquarters is located in Los Angeles, CA, US.
Aya Biosciences' most recent funding round was for $5M (USD) in June 2021.
As of Jun 29, 2021, Aya Biosciences has raised a total of $5M (USD).
Aya Biosciences has 6 employees as of Feb 5, 2024.